PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10484455-4	1999	Significant enhancement of [(3)H]thymidine incorporation in HASM cultures was observed only by treatment with agents (epidermal growth factor, platelet-derived growth factor, thrombin, and phorbol 12-myristate 13-acetate) that promoted a strong and sustained activation of p42/p44 MAPK.	Thymidine	33-42	cyclin dependent kinase 20	Homo sapiens	273-276	
16030168-14	2005	Stimulation of p42/44 MAPK phosphorylation reflected the behavior of thymidine uptake.	Thymidine	69-78	cyclin dependent kinase 20	Homo sapiens	15-18	
11053031-4	2000	HGF was found to significantly increase [(3)H]thymidine incorporation within 5 h; peak thymidine incorporation was observed at 16 h. However, when cells were pretreated with inhibitors of p42/p44 (PD-98059), p38 (SB-203580), or PKC (GF-109203X, Go-6983, or myristoylated inhibitor peptide(19-27)), HGF-induced thymidine uptake was diminished in a dose-dependent manner.	Thymidine	87-96	cyclin dependent kinase 20	Homo sapiens	188-191	
11053031-4	2000	HGF was found to significantly increase [(3)H]thymidine incorporation within 5 h; peak thymidine incorporation was observed at 16 h. However, when cells were pretreated with inhibitors of p42/p44 (PD-98059), p38 (SB-203580), or PKC (GF-109203X, Go-6983, or myristoylated inhibitor peptide(19-27)), HGF-induced thymidine uptake was diminished in a dose-dependent manner.	Thymidine	87-96	cyclin dependent kinase 20	Homo sapiens	188-191